Spanish enforcer probes nuclear medicine

Spain’s antitrust enforcer is investigating an alleged cartel between two nuclear imaging companies, while also examining if one of them abused its dominant position in the radiopharmaceuticals market.

Get unlimited access to all Global Competition Review content